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Continuous ambulatory peritoneal dialysis (CAPD): A 5-year evalu.
ation (A multicenter survey including 345 patients). C. Verger. B. Faller,
J. P. Ryckelynck, R. Guiberteau, D. Pierre, D. Benevent, and C.
Wone. Services de Nephrologie des Hopitaux de Pontoise, Co/mar,
Caen. Bourges, Orleans, Litnoges, and Bordeaux, France. In France
CAPD has been used for 5 years. A multicenter study was performed
to evaluate the results of the method and its place in the treatment of
chronic renal failure (CRF). Seven centers pooling 345 patients trained
between May 1978 and August 1983 collaborated. Cumulative treat-
ment duration was 441 patient-years: 81 have been followed-up for
more than 2 years, among them 24 for more than 3 years and 4 for more
than 4 years. Technique success rate (TSR) and cumulative patient sur-
vival (CPS) were calculated by applying actuarial methods. In TSR we
considered as treatment failures both deaths and drop-outs due to
transfer to an alternative form of dialysis. Transplanted patients were
considered as lost to follow-up at the time of transplantation. In CPS
only deaths were considered as drop-outs. Transplanted patients or
those who were transferred to an alternative dialysis modality were
considered as lost to follow-up at the time they left CAPD. Seventeen
patients were transplanted. Between May 1978 and August 1983, 3-
year TSR was 53.4% in patients under 55 years and 32.8% over (P <
0.001); CPS at 3 years are 78 and 44.6%. respectively, before and after
the age of 55 (P < 0.001). Mean age was not different before and after
May 1981, but TSR at 2 years increased from 46.2 to 69.6% and CPS
from 61.7 to 87.1%. In subjects younger than 50 and trained after May
1, 1981, the TSM at 2 years is 75.9% and CPS is 94.9%; peritonitis was
responsible for 32.9% of total drop-outs. Whatever patient age, sur-
vival on CAPD has dramatically improved during the last 2 years. in
the participating centers 28.9% of dialyzed patients were on CAPD at
home compared to 17.2% hemodialyzed at home and 53.8% in a hos-
pital, demonstrating that CAPD can play an important role in the treat-
ment of CRF at home. In this case, 2-year survival reaches 94.9% in
patients under 50 years of age.
Gold nephropathy with minimal glomerular changes. J. P. Ryck-
elynck, J. F. Girard, P. Mignot, D. Nochy, A. Ga/let, and J. L. Feld-
man. Service de NCphrologie, ('HG ClCmenceau Caen, and ('unique
Médicale Service de Nephrologie, Ilôpital Broussais, Paris, France.
Morphologic studies of renal biopsy specimens were obtained from two
patients who received aurothiopropanol for rheumatoid arthritis. In
both patients a nephrotic syndrome appeared and treatment had to be
discontinued. Percutaneous kidney biopsy showed minimal glomerular
changes by light microscopy whereas no deposits were noted in im-
munofluorescence studies. Amyloid stains were negative. By ultras-
tructural microscopy epithelial cell foot-process fusion was present but
electron-dense deposits indicative of membranous glomerulonephritis
were not seen. Gold granules were seen within proximal tubular epi-
thelial cells. In one patient proteinuria became negative within 14
months whereas a 24-hr protein excretion of 2.1 g persisted in the other
patient. These findings suggest that a nephrotic syndrome with mini-
mal glomerular changes may occur during gold therapy.
Treatment of systemic lupus with cyclosporin A: A patient with a 1.
year follow-up. N. LeFrancois, P. Deleix, M. Laville, P. Zech, and J.
Traeger. Clinique de Nephrologie et Maladies MCtaboliques, Hôpital
Edouard-Herriot, Lyon, France. A 34-year-old woman had for 8 years
relapses of severe systemic lupus erythematosus (SLE). She has been
treated for 1 year by cyclosporin A. Until last year she received ster-
oids and immunosuppressive drugs, and plasma exchanges were per-
formed. Cortico-dependence appeared below 20 mg/day of predni-
sone. Renal involvement was focal segmental glomerulonephritis. Cy-
closporin A was started in December 1982. Dosage was 3 mg/kg orally
every 12 hr. Twice a month cyclosporin A blood level was checked by
radioimmunoassay (141 73 ng/ml). Clinical status was regularly
evaluated and tests for renal function (creatininemia, proteinuria),
lupus (anti-nuclear antibodies and anti-DNA antibodies), complement
fractions (C3.C4), and hepatic function were regularly performed. The
treatment induced a good clinical and biological response. Prednisone
dosage was decreased to 10 mg/day and steroid side effects dis-
appeared. Renal function has deteriorated very slightly, but no other
toxic effect of cyclosporin A has been observed. Cyclosporin A, a new
immunosuppressive drug used mainly in transplantation is a relatively
selective immunosuppressant for helper T lymphocytes. A beneficial
effect was reported in NZB mice, probably by diminution of B lympho-
cyte polyclonal stimulation, It seems logical to try cyclosporin A in the
treatment of severe SLE poorly controlled by usual drugs.
Relative contribution of hypoventilation and intrinsic lung dysfunction
to hemodialysis (HD)-induced hypoxemia. A. Kanfer, F. Blanchet, R.
Georges, E. Cramer, J. P. Mér9, and C. Amid Services de
Néphrologie, d'Exploraiions Fonctionnelles et d'Hematologie, Hdpital
Bichat. Paris. France. Two main mechanisms have been proposed to
explain HD-induced hypoxemia: alveolar hypoventilation due to loss
of CO2 in acetate dialysate and intrapulmonary leukostasis related to
exposure of blood to the dialyzer membrane. The relative importance
of these two mechanisms was assessed in seven chronically uremic pa-
tients with normal basal respiratory function. Each patient was stud-
ied during a 4-hr HD with acetate dialysate (AHD) and during another
4-hr-HD with bicarbonate dialysate (BHD); all HD were performed
with the same type of cuprophan membrane. The following measure-
ments were made before HD and 45, 90, 180. 240 mm after the begin-
ning of HD: arterial blood gas pressure, 02 and CO2 in expired gas, 02
uptake (V02), CO2 output (VCO2), respiratory exchange ratio (R), al-
veolar ventilation (VA). alveolo-arterial 02 difference [D(A-a)021, CO
pulmonary diffusing capacity (DLCO). and white blood cell (WBC)
counts, with an additional study at 15 mm for the latter. Results are
expressed as percent of pre-HD values (mean SCM). ,We observed a
significant decrease (P < 0.01) in PaO2, VCO2, R and VA only during
AHD; for instance at 90 mm: Pa02 = 90 1.8%, VCO2 = 81 4.5%,
R = 80 1.7%, VA 79 3.2%: Pa02 and VA were positively cor-
related (P < 0.001). We observed a significant decrease in DLCO and
WBC counts of the same magnitude in both types of HD (thai is, in
the hypoxemic AHD patients and the nonhypoxemic BUD patients)
without changes of [D(A-a)O2]. In conclusion, intrapulmonary leuko-
stasis reflected by the DLCO decrease does not seem to be a crucial
factor in HD-induced hypoxemia: Hypoxemia is essentially related to
hypoventilation due to a loss of CO2 in acetate dialysate.
Terminal C5b-9 complex of complement is found in subepithelial de-
posits of idiopathic membranous nephropathy (MN) but not in those of
toxic MN. N. Hinglais, M. Kazatchkine, S. Bhakdi, andi. Bariety. IN-
SERM U 28, Hôpital Broussais, Paris, France. Biospy specimens from
four patients with idiopathic membranous nephropathy (MN) and from
ten patients with gold or D-penicillamine induced MN have been ex-
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amined by indirect immunofluorescence using a monospecific antibody
to the neoantigens expressed by the terminal C5b-9 complex of human
complement. In all biopsy specimens from patients with idiopathic
MN, large subepithelial deposits were intensely stained with anti-IgG
and anti-C5b-9, and weakly stained with anti-C3 in one patient. In toxic
MN, subepithelial deposits were of smaller size and stained for IgG in
all patients but not for C5b-9 neoantigens. Staining with anti-C3 was
found in two often biopsy specimens. In all patients with MN, whether
idiopathic or toxic, a finely granular staining with anti-C5b-9 was found
in the mesangium similar to the staining that we have previously ob-
served in normal human kidneys, The presence of C5b-9 neoantigens
in subepithelial deposits of idiopathic but not of toxic MN suggests ei-
ther that the terminal complement sequence is not similarly involved
in the pathogenesis of both forms of MN; or that C5b-9 does not par-
ticipate in the initial subepithelial deposition of immune material in
MN, since patients with toxic MN were seen at an earlier phase of the
disease than those with idiopathic MN.
Idiopathic edema (lE) in a man: Comparative study of the effect of
captopril (C), spironolactone (S), and C + S association on orthostatic
urinary excretion. A. HadjAissa, P. Deteix, N. LeFrancois, N. Pozet,
M. Vincent, and J. Traeger. Clinique de Néphrologie et INSERM U
80 - Hôpital Edouard Herriot, Lyon, France. A 34-year-old male hav-
ing orthostatic induced IE was treated for 10 days (D), from D1 to D10,
by C (100 mg/D), and following a 10-day washout period, by S (200
mg/D) from D21 to D30, and finally by C + S from D31 to D40. An acute
oral water load (20 mi/kg body weight, ingested within 15 mm) was
given in an upright position at D0 (control), D10, D30, and D40. Urine
specimens were collected every hour for 5 hr and blood samples were
taken before and 5 hr after water load. The following main results were
found:
5-hr cumulative diuresis,
% of water load
Fractional Na excretion %,
mean of5 hr 0.03 0.24 0.33 0.63
Urinary Na/K, mean of 5 hr
On the test day, plasma renin activity (ng/liter/min) ranged from 216 to
368 at D0 from 310 to 650 after C, from 850 to 673 after 5, and from
636 to 1104 following C + S. In this study of lE, C and S were equipo-
tent on orthostatic natriuresis while C + S had greater effect. Thus,
the natriuretic effect of S was potentiated by the addition of C, S had
no effect on CH,O while C alone or C + S led to a similar increase in
CH2O. Thus, C had a specific effect on free-water excretion.
Value of ultrasonography (US) for assessment of retroperitoneal he-
matomas (RPH) after percutaneous renal biopsy (PRB). J. Hachicha, S.
Dard, F. Cornud, A. Sihert, and J. P. Méry. Services de Néphrologie
et de Radiologie. Hópital Bichat, Paris, France. A prospective US
study was performed in 57 patients (mean age, 43 years) who under-
went a PRB between August 1982 and July 1983. All had an IVP and a
US 24 or 48 hr before PRB, and a post-PRB US within a mean of 2
days (extremes, Ito 6 days) after the biopsy. A Vim-Silverman-Frank-
lin needle was used and two fragments of renal tissue were obtained
from all patients. Most underwent two renal punctures; however, due
to failure of some punctures to reach the kidney, 27 of them had more
than two punctures in the lumbar fossa. The following parameters were
obtained for all patients: evaluation of possible weight excess,
eyeground, serum creatinine level, thickness of the lower pole of the
kidney assessed as the US distance between the bottom of the calices
and the capsula; the presence of medulla within the fragments was also
recorded. An RPH, mostly of minimal or moderate abundance, was de-
tected in eight patients (14%); seven of whom had a primary glomer-
ular disease and one a primary vascular disease. Two RPH were clini-
cally silent, one was associated with gross hematuria, one with marked
lumbar pain, and four with both symptoms. Resolution of all RPH was
documented by serial US. A significant correlation (P < 0.05) was
found between the occurrence of RPH and each of the following pa-
rameters: number of punctures., absence of medulla within the renal
fragments, and occurrence of lumbar pain after the biopsy. On the con-
trary, there was no significant correlation with weight, hypertensive ret-
inopathy, or renal failure, nor with the thickness of the low pole of the
kidney or with the occurrence of a post-PRB gross hematuria. In con-
clusion, these results demonstrate the value of US for assessment of
post-PRB RPH which cannot be accurately diagnosed on a clinical ba-
sis only.
Impairment of distal tubular function in patients with calcium nephro-
lithiasis. H. Favre and M. Megevand. Division of Nephrology, Depart-
ment of' Medicine, Urologic Clinic, Department of Surgery, University
of Geneva, Geneva, Switzerland. Statistical analysis has recognized
three factors correlated with nephrolithiasis: (1) hyperoxaluria, (2)
hypercalciuria, and (3) urinary pH. Therefore, 29 nonobstructive pa-
tients with recurrent calcium nephrolithiasis were investigated for their
capacity to acidify their urine. They were separated into three groups
on the basis of a calcium loading test and compared to a control group:
normocalciuric, group A (N = 9); renal hypercalciuric, group B (N =
12); absorptive hypercalciuric, group C (N = 8); and control (N = 8).
In patients and control subjects, urinary pH was measured in the first
morning urine specimen. Urine blood (U-B) Pco2 gradient in maxi-
mally alkaline urine and maximum acidification of the urine after a 3-
D C S C + s day ammonium chloride load were obtained. Basal urinary pH was 5.3
____________________________ 0.1 SEM in control group versus 5.4 0.1, 6.1 1.0, 5.8 0.2 in
groups A, B, and C, respectively (P < 0.05). Patients from the three
43 67 43 66 nephrolithiasis groups failed to increase their U-B Pco2 gradient nor-
mally; control, 30.9 2.1 mm Hg versus 25.1 4.4, 22.1 2.5, 24.9
4.2 for groups A, B, and C, respectively (P < 0.05). After acid load,
patients from the three groups were able to lower their urinary pH to
the level of the control groups but were unable to increase their NH4
excretion normally (NH4 sEq/min 76.6 14.4 control versus 54.6
9.1, 59.3 4.3, 64.3 5.4 groups A, B, and C, respectively) (P <
0.05). In conclusion, patients with calcium renal stones had two distal
tubular defects: (1) an impairment of hydrogen ion secretion; (2) an in-
capacity of increasing their ammonium excretion after acid load. These
defects may contribute to the stone formation.
Maximum urinary output, mi/mm
Maximum free-water excretion,
CH2O, mi/mm
5-hr cumulative natriuresis,
UNaV, mmoles
7.67 12.82 8.28 13.70
5.09 8.77 4.89 8.54
1.6 17 18 41
0 12 0 92 1 13 1 44 2.8 Di-hydroxyadenine (2.8 OHA) urolithiasis in an adult - Complete
adenine phosphoribosyl transferase (APRT) deficiency - Family study. D.
Chever, P. Le Pogamp, S. Gié, J. Gary, M. Daudon, and M. Hamet.
Néphroiogie, CHU, Rennes, Laboratoire Cristal, Saint Cloud, and
Biochimie, Hôpital Necker, Paris, France. In June 1983 acute pyelone-
phritis occurred in a 48-year-old woman without pathological anteced-
ent. A radiotransparent unilateral ureteral obstructive lithiasis was dis-
covered. Creatininemia was 168 moles/liter, creatinine clearance, 31
mi/mn: plasma uric acid, 291 zmoles/liter; uric acid clearance, 4.53
mi/mn; and urinary pH, 7.1. She rapidly improved with adequate
therapy. Microlithiasis was present in the urine. Infrared spectropho-
tometry (IRS) study of the fragments showed identical spikes on each
which are composed of 2.8 OHA. Complete APRT deficiency sug-
gested by the nature of the urinary stones is confirmed by the lack of
erythrocyte activity of the enzyme 0.0014 U (Unite = 1 mmole
AMP/mg protein, to 37°C — normal = 26.9 4.9 U). Abundant diure-
sis, restricted purine intake, and 100 mg daily Allopurinol induce the
disappearance of 2.8 OHA crystalluria. The family study (31 persons)
shows one asymptomatic homozygous brother and 14 heterozygous.
(1) This is the first adult case of complete APRT deficiency reported in
France (six other cases in the world). (2) Diagnosis can only be based
on IRS, which alone allows detection of 2.8 OHA in crystalluna or uri-
nary stones, because other chemical methods cannot distinguish 2.8
OHA from uric acid. (3) In the case of complete APRT deficiency, ad-
enine accumulates in the body and becomes a substrate for xanthine
oxydase which changes it into 2.8 di-OHA. Consequently allopurinol
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is logical effective therapy. (4) IRS screening effectively detects spon-
taneous urinary crystalluria in homozygous as well as verifying the ef-
ficiency of allopurinol therapy.
tive increase in Na passive permeability in Bartter syndrome which
is not observed in patients with acquired hypokalemia. This primary
defect argues for a generalized membrane defect in Bartter syndrome.
Erythrocyte Na and K transport systems in hypokalemia: Only
Bartter syndrome is associated with increase in passive sodium perme-
ability. J. P. Brunois, R. Vistelle, T. Mi/cent, 0. Toupance, H. Choisy,
and J. Chanard. Centre Hospitalier ci Universitaire, Reims, France.
Erythrocyte Na and K transport systems were investigated in 13 ad
ult patients with hypokalemia (three among them with Bartter syn-
drome) and in 83 healthy control subjects. The aim of the study was to
characterize the specificity of the increase of passive sodium perme-
ability documented in children with Bartter syndrome. Na and K
ouabain sensitive fluxes (pump), Na and K furosemide sensitive
fluxes (co-transport), and the rate constant of passive Na and K * per-
meability were measured. The most striking result was the significant
increase in the rate constant of passive Na* permeability in patients
with Bartter syndrome when compared with hypokalemia of other ori-
gins (0.031 0.005 vs. 0.017 0.003, P < 0.001). No change in pas-
sive K permeability was documented. The maximal rate of ouabain
sensitive Na* efflux was in the same range in the two subgroups of
hypokalemia; however, in Bartter syndrome a slight increase was mea-
sured compared to healthy control subjects. All patients with hypokal-
emia had Na* and K* co-transport fluxes similar to those measured
in hypertensive control subjects and significantly lower than those
measured in normotensive control subjects. This study shows a selec-
Renal and hepatic immunohistopathology of cirrhosis. M. C. Bene, G.
Faure, J. Dc Korwin, B. Dc Ligny, M. Kessler, P. Gaucher, and J.
Duheille. Laboratoire d'I,nmunologie et Services de Médecine C et de
Nephrologie, Faculté de Médecine et CHU de Nancy, Nancy, France.
Clinical signs of glomerular lesions were sought in 81 local ethylic cir-
rhosis patients. Twenty were endstage patients. Kidney and liver bi-
opsy specimens were obtained within 12 hr after death. Glomerular ex-
ploration included assessment of hematuria, proteinuria, uremia, and
creatininemia. Serum IgA was also measured. Alteration of glomerular
functions was observed in seven patients out of 81, three of them in
the endstage group. Light microscopy showed glomerular lesions in
one of the 20 deceased patients. In immunofluorescence, mesangial
IgA were found in one, minor paramesangial IgA in one, and endome-
mbraneous IgA and 1gM in three, while six biopsy specimens con-
tained segmental deposits of complement factors. IgA-secreting plasma
cells were observed amidst inflammatory infiltrates in the fibrous tis-
sue of liver biopsy specimens of II patients out of 17, associated with
1gM-secreting plasma cells in two patients. Immunoglobulin deposits
were not seen in these livers, and secretory component was not ob-
served in livers or kidneys. These results indicate a very low fre-
quency of renal disease in ethylic cirrhosis patients. Mesangial IgA
nephropathy was diagnosed in one patient out of 20.
